Uridine and uridine analogues for treatment of specific lung diseases, namely COPD and pulmonary fibrosis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9795625
APP PUB NO 20160220597A1
SERIAL NO

15096756

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the new indications of chronic obstructive pulmonary disease (COPD) and idiophathic lung fibrosis (IPF) for uridine and uridine analogs.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITAETSKLINIKUM FREIBURGHUGSTETTER STRASSE 49 FREIBURG D-791

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Idzko, Marco Freiburg, DE 3 1
Sorichter, Stephan Freiburg, DE 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 24, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 24, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00